Join us for a Pink Ribbon Walk this spring Choose from 4 incredible walks, each in an iconic destination surrounded by spectacular scenery. 10 or 20 mile options are available.
Book a Public Health Talk Raise awareness of breast cancer in your local community or network by booking a free online or in-person talk.
Home About us Media Breast Cancer Now media statements 193 results We respond to report revealing more than one in four premature deaths in UK 'will be due to cancer by 2050' 21 Nov 2024 1 min read We respond to NICE guidance to not recommend Enhertu for HER2-low secondary breast cancer remaining unchanged 19 Nov 2024 1 min read We respond to the National Cancer Medicines Advisory Group in Scotland supporting use of anastrozole, tamoxifen and raloxifene to reduce risk of breast cancer 24 Oct 2024 1 min read We respond to new research that suggests women who use a contraceptive coil may have a slightly higher risk of developing breast cancer 17 Oct 2024 1 min read We respond to news that a blood test could detect 12 most common cancers before symptoms develop 08 Oct 2024 2 min read We respond to NICE provisional decision to not recommend elacestrant in England 01 Oct 2024 1 min read We respond to NICE Board decision to not make changes to severity modifier 25 Sept 2024 2 min read Our response to new analysis from Cancer Research UK revealing more than 300,000 cancer patients face delays over the next five years 20 Sept 2024 1 min read We respond to the National Audit of Metastatic Breast Cancer State of the Nation Report 2024 12 Sept 2024 1 min read We respond to Elle Macpherson sharing her breast cancer diagnosis 7 years ago 03 Sept 2024 1 min read Breast Cancer Now respond to devastating NICE decision to not recommend life-extending breast cancer drug Enhertu in England 29 Jul 2024 2 min read We respond to Royal College of Radiologists' 2023 Clinical Radiology and Oncology Census Reports 13 Jun 2024 1 min read Previous 1 ... 3 ... 17 Next
We respond to report revealing more than one in four premature deaths in UK 'will be due to cancer by 2050' 21 Nov 2024 1 min read
We respond to NICE guidance to not recommend Enhertu for HER2-low secondary breast cancer remaining unchanged 19 Nov 2024 1 min read
We respond to the National Cancer Medicines Advisory Group in Scotland supporting use of anastrozole, tamoxifen and raloxifene to reduce risk of breast cancer 24 Oct 2024 1 min read
We respond to new research that suggests women who use a contraceptive coil may have a slightly higher risk of developing breast cancer 17 Oct 2024 1 min read
We respond to news that a blood test could detect 12 most common cancers before symptoms develop 08 Oct 2024 2 min read
We respond to NICE provisional decision to not recommend elacestrant in England 01 Oct 2024 1 min read
Our response to new analysis from Cancer Research UK revealing more than 300,000 cancer patients face delays over the next five years 20 Sept 2024 1 min read
We respond to the National Audit of Metastatic Breast Cancer State of the Nation Report 2024 12 Sept 2024 1 min read
We respond to Elle Macpherson sharing her breast cancer diagnosis 7 years ago 03 Sept 2024 1 min read
Breast Cancer Now respond to devastating NICE decision to not recommend life-extending breast cancer drug Enhertu in England 29 Jul 2024 2 min read
We respond to Royal College of Radiologists' 2023 Clinical Radiology and Oncology Census Reports 13 Jun 2024 1 min read
